The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis
Clinical trial NCT03105505 · UNKNOWN
Trial details
- NCT number
- NCT03105505
- Sponsor
- Barzilai Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-28
- Primary completion
- 2018-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.